Enhancing global and mRNA specific translation for improved recombinant protein expression in in vitro cultured mammalian cells
Lead Research Organisation:
MRC Toxicology Unit
Department Name: MRC Toxicology Unit
Abstract
Many of the new drugs currently under development are based upon proteins rather than traditional small molecules (e.g. antibiotics). One of the type of protein molecules that is particularly challenging to make are antibodies e.g. herceptin. These protein drugs are produced for the treatment of diseases such as cancer by cells kept in culture under defined conditions. One problem with this is that the cells we use to make proteins for therapeutic uses are not as efficient as we would like them to be and therefore we may not be able to produce enough of these drugs and the cost and demand for them is high. Protein synthesis is the process by which the information in the genetic material in the cell, DNA is converted via an intermediary substrate mRNA, into proteins. For proteins to be synthesised the mRNA must interact with a large complex called the ribosome which consists of RNAs and proteins. Ribosomes are able to decode the genetic information that is held in the mRNA and carry out the synthesis of the proteins. There are two distinct mechanisms by which mRNAs can interact with the ribosomes. The most common mechanism requires the binding of a protein complex to the 5' end of the mRNA and this complex then recruits the ribosome. However, certain mRNAs contain 5' regions that do not code for sections of proteins (termed untranslated regions; UTRs) and these sequences of RNA harbour the information that is required to form a complex RNA structure. These RNA structures allow the ribosome to be recruited to the mRNA generally a considerable distance from the 5' end and so this method of ribosome recruitment has been termed internal ribosome entry. Interestingly, messages that use internal ribosome entry generally encode proteins that are used under situations of cell stress including under temperature reduction (cold-shock). This information is of industrial relevance since the production of commercially valuable proteins (e.g. antibodies) is hindered when cells become stressed later in culture and by the cold-shock that is commonly induced during fermentation. We aim to use the 5' UTRs of mRNAs that are translationally active during cold-shock to enhance the production of proteins that are important to industry. Achieving this is very important as it is expected that with an increasing number of protein 'drugs' being developed we will lack the capability of producing large enough amounts to meet the required demand for these new drugs for the majority, as opposed to for those who can afford what must currently remain prohibitively expensive, but very effective, medicines.
Technical Summary
The ability of industrially relevant expression systems to produce recombinant protein (rP) has advanced considerably in recent years, however despite such advances our understanding of the cellular processes that determine/limit rP yield from in vitro cultured mammalian cells remains poor. Recent reports suggest that the limitations are at least partially linked to modulation of translation, the mechanism(s) by which mRNAs interact with/are loaded onto ribosomes, mRNA turnover and sequestration, and control elements within the non-coding regions (UTRs) of mRNAs. Despite such reports, whether these control mechanisms can be manipulated to enhance the translation of specific recombinant mRNAs and ultimately enhance rP synthesis under 'normal' (37degC) and sub-physiological (32degC) culture temperatures within the same fermentation in an industrially relevant manner remains open to question. The proposed programme of work will test the hypothesis that via modulation of global translation, over-expression of mRNA chaperones, and by utilising components of the 5' and 3'-UTRs of endogenous mRNAs, recombinant mRNA specific translation can be enhanced in mammalian cells in a controlled and predictable manner to increase rP yields. We will utilise a combination of molecular and protein based approaches to characterise the links between mRNA translation factors and the control of their activity, mRNA chaperones, mRNA UTRs, protein synthesis, and gene expression that are implicated in the cellular responses governing/limiting rP yield. The outcomes will be (i) an understanding of those mechanisms governing recombinant mRNA translation under biphasic temperature culturing conditions of in vitro cultured mammalian cells, (ii) the design of new approaches to modulate global mRNA expression in an industrial context, and (iii) the rational development of plasmid vectors to allow enhanced translation of recombinant mRNAs during bioprocessing.
Organisations
People |
ORCID iD |
Anne Willis (Principal Investigator) |
Publications
Bastide A
(2017)
RTN3 Is a Novel Cold-Induced Protein and Mediates Neuroprotective Effects of RBM3.
in Current biology : CB
Faller WJ
(2015)
mTORC1-mediated translational elongation limits intestinal tumour initiation and growth.
in Nature
Knight JR
(2013)
Active regulator of SIRT1 is required for ribosome biogenesis and function.
in Nucleic acids research
Knight JR
(2016)
Cooling-induced SUMOylation of EXOSC10 down-regulates ribosome biogenesis.
in RNA (New York, N.Y.)
Knight JR
(2015)
Eukaryotic elongation factor 2 kinase regulates the cold stress response by slowing translation elongation.
in The Biochemical journal
Pichon X
(2012)
RNA binding protein/RNA element interactions and the control of translation.
in Current protein & peptide science
Roobol A
(2014)
The chaperonin CCT interacts with and mediates the correct folding and activity of three subunits of translation initiation factor eIF3: b, i and h.
in The Biochemical journal
Roobol A
(2011)
ATR (ataxia telangiectasia mutated- and Rad3-related kinase) is activated by mild hypothermia in mammalian cells and subsequently activates p53.
in The Biochemical journal
Roobol A
(2015)
p58IPK is an inhibitor of the eIF2a kinase GCN2 and its localization and expression underpin protein synthesis and ER processing capacity.
in The Biochemical journal
Description | Cooling is used in industrial biotechnology to enhance the production of biologically therapeutically relevant proteins such as insulin. We have shown how the overall rate of protein synthesis is affected by cooling and this understanding will help to over come these issues and boost production. |
Exploitation Route | Industry will be able to use our findings to increase protein production in cooled cells. |
Sectors | Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology |
Description | BBSRC project grant: Defining novel mechanisms of mRNA translational control on cold shock |
Amount | £340,000 (GBP) |
Funding ID | BB/I019790/1 |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 09/2012 |
End | 10/2015 |
Description | Wellcome Trust collaborative award |
Amount | £2,000,000 (GBP) |
Organisation | Wellcome Trust |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 10/2016 |
End | 09/2021 |
Description | Brooke Priory school visit |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Type Of Presentation | Workshop Facilitator |
Geographic Reach | Local |
Primary Audience | Schools |
Results and Impact | 30 children spent a day making DNA in the Unit. They had 2 lectures one of which I presented About half the children decided that they would like to be scientists but they were only 10! |
Year(s) Of Engagement Activity | 2012 |
Description | RNA UK cumbria conference |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other academic audiences (collaborators, peers etc.) |
Results and Impact | stimulated interest in our research Amandine Bastide from my laboratory was awarded a prize for best talk |
Year(s) Of Engagement Activity | 2014 |
Description | School lecture |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Type Of Presentation | Paper Presentation |
Geographic Reach | Regional |
Primary Audience | Schools |
Results and Impact | Lecture on theory of knowledge and how scientific theories are developed to year 11 IB students Increased appreciation of scientific thought. |
Year(s) Of Engagement Activity | 2012 |
Description | Seminar Human Genetics Unit Edinburgh |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Type Of Presentation | Keynote/Invited Speaker |
Geographic Reach | National |
Primary Audience | Other academic audiences (collaborators, peers etc.) |
Results and Impact | MRC Human Genetics Unit, Edinburgh Interest in work from colleagues |
Year(s) Of Engagement Activity | 2013 |
Description | Seminar Queens University Belfast |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Type Of Presentation | Keynote/Invited Speaker |
Geographic Reach | National |
Primary Audience | Other academic audiences (collaborators, peers etc.) |
Results and Impact | September 24 - Centre for Cancer Research & Cell Biology, Queens University, Belfast. Interest in research area |
Year(s) Of Engagement Activity | 2013 |
Description | Seminar Sanquin Research |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Type Of Presentation | Paper Presentation |
Geographic Reach | International |
Primary Audience | Other academic audiences (collaborators, peers etc.) |
Results and Impact | 100 researchers attended talk. Seminar and Masterclass, Sanquin Research & Landsteiner Lab., Amsterdam new collaborations |
Year(s) Of Engagement Activity | 2012,2013 |
Description | Seminar University of Surrey |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | Yes |
Type Of Presentation | Keynote/Invited Speaker |
Geographic Reach | National |
Primary Audience | Other academic audiences (collaborators, peers etc.) |
Results and Impact | May 23 - Dept. of Microbiological & Cellular Sciences, University of Surrey new collaborations |
Year(s) Of Engagement Activity | 2013 |
Description | Seminar University of Tor Vergata Rome |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Type Of Presentation | Keynote/Invited Speaker |
Geographic Reach | International |
Primary Audience | Other academic audiences (collaborators, peers etc.) |
Results and Impact | Pharmacy Summer School, University of Tor Vergata, Rome Attended by students who showed interest in the research area |
Year(s) Of Engagement Activity | 2013 |
Description | Seminar to University of Rome Tor Vergata |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other academic audiences (collaborators, peers etc.) |
Results and Impact | Research seminar, many questions important new interactions |
Year(s) Of Engagement Activity | 2014 |
Description | Seminar to University of Würzburg, Germany |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other academic audiences (collaborators, peers etc.) |
Results and Impact | Research talk stimulated interest formal collaborations established |
Year(s) Of Engagement Activity | 2014 |
Description | TV interview |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | Gave TV interviews about the Unit's research to ITN, BBC East midlands todays, ITV Central, Sky News and Chanel 5 news. Huge interest in the Unit's science from the public. |
Year(s) Of Engagement Activity | 2013 |
Description | Unit Open day |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | Yes |
Type Of Presentation | Keynote/Invited Speaker |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Over 500 members of the pubic visited the Unit Member of the public were very appreciative. Students asked to come and carry out work experience in the Unit |
Year(s) Of Engagement Activity | 2013 |
Description | conference Roscoff |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Type Of Presentation | Paper Presentation |
Geographic Reach | International |
Primary Audience | Other academic audiences (collaborators, peers etc.) |
Results and Impact | Talk to colleagues, new collaborations established |
Year(s) Of Engagement Activity | 2012 |